Latest

University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆ The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape ◆ The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆ The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape ◆ The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Updated 11 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Bristol

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

21

Recruiting now

23

Studies tracked

Bristol

Selected city

Recruiting Phase 3

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Amgen · started 2025-07-25

📍 Birmingham · Blackpool · Bristol · Cambridge · Chester

NCT07037433 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals · started 2024-10-09

📍 Basingstoke · Bristol · London

NCT06470048 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLC · started 2023-12-13

📍 Bristol · Lancaster · London · Oxford · Newmarket

NCT06136559 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease
Immunovant Sciences GmbH · started 2024-12-17

📍 Birmingham · Bristol · Coventry · London · Cambridge

NCT06727604 on ClinicalTrials.gov ↗

Recruiting Phase 2

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH · started 2025-03-18

📍 Bristol · Glasgow · Salford · Southampton

NCT07032662 on ClinicalTrials.gov ↗

Recruiting Phase 3

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
Alnylam Pharmaceuticals · started 2025-09-22

📍 Ashburton · Belfast · Bellshill · Birmingham · Bristol

NCT07181109 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Gastroesophageal Adenocarcinoma
AstraZeneca · started 2025-07-17

📍 Bristol · Dundee · Headington · London · Norwich

NCT07069712 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Regeneron Pharmaceuticals · started 2024-10-30

📍 Liverpool · York · Bristol · London · Newcastle upon Tyne

NCT06541704 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration
Novartis Pharmaceuticals · started 2026-03-09

📍 Bristol · London

NCT07441642 on ClinicalTrials.gov ↗

Recruiting Phase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim · started 2024-09-17

📍 Aberdeen · Ashton in Makerfield · Bristol · Camberley · Edgbaston, Birmingham

NCT06632444 on ClinicalTrials.gov ↗

Starting soon Phase 3

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Systemic Sclerosis
Boehringer Ingelheim · started 2026-07-10

📍 Bristol · Salford

NCT07497087 on ClinicalTrials.gov ↗

Recruiting Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Boehringer Ingelheim · started 2025-07-22

📍 Birmingham · Blackburn · Bournemouth · Bradford · Bristol

NCT07064473 on ClinicalTrials.gov ↗

Recruiting Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim · started 2025-06-09

📍 Belfast · Birmingham · Blackpool · Bradford · Bristol

NCT06872892 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

Chronic Kidney Disease
Boehringer Ingelheim · started 2025-12-09

📍 Birmingham · Bristol · Glasgow · Liverpool · London

NCT07107945 on ClinicalTrials.gov ↗

Active Phase 3

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer · started 2014-12-17

📍 Glasgow · Wonford · London · Sutton · Birmingham

NCT02319837 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Heart Failure
Boehringer Ingelheim · started 2024-06-17

📍 Barnet · Bristol · Exeter · Halifax · High Wycombe

NCT06424288 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine
Pfizer · started 2025-03-11

📍 Bristol · Milton Keynes · Hull · London · Fazakerley

NCT06641466 on ClinicalTrials.gov ↗

Recruiting Phase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim · started 2024-11-07

📍 Aberdeen · Bristol · Camberley · Derby · Edgbaston, Birmingham

NCT06632457 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Boehringer Ingelheim · started 2024-05-06

📍 Aberdeen · Birmingham · Bristol · Edinburgh · Exeter

NCT06238622 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure
Boehringer Ingelheim · started 2025-05-20

📍 Bristol · Clydebank · Exeter · Halifax · Harrow

NCT06935370 on ClinicalTrials.gov ↗

Recruiting Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy
Pfizer · started 2025-08-25

📍 Bristol · London · Manchester · Truro · Southampton

NCT07160244 on ClinicalTrials.gov ↗

Recruiting

Registry for Patients With X-Linked Hypophosphatemia

X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd · started 2017-09-12

📍 Belfast · Birmingham · Bristol · Cambridge · Cardiff

NCT03193476 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. · started 2024-03-13

📍 High Wycombe · Bristol · Glasgow · Hull · London

NCT06318169 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 118 Manchester · 30 Glasgow · 27 Cambridge · 27 Birmingham · 24 Leicester · 23 Bristol · 23 Leeds · 22 Sutton · 19 Oxford · 19 Liverpool · 18 Edinburgh · 15 Nottingham · 14 Cardiff · 14 Newcastle upon Tyne · 13 Sheffield · 12

Browse by condition

Obesity · 5 Chronic Lymphocytic Leukemia · 5 Cancer · 4 Breast Neoplasms · 3 Non-small Cell Lung Cancer · 3 Small Lymphocytic Lymphoma · 3 Multiple Myeloma · 3 Hypertension · 3 Heart Failure · 3 Triple Negative Breast Neoplasms · 2 Lymphoma, Non-Hodgkin · 2 Lymphoma, Follicular · 2 Lymphoma, Large B-Cell, Diffuse · 2 Gastric Cancer · 2 Metastatic Prostate Cancer · 2 Overweight · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/bristol (Accessed: 11 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.